Zeuschner P - Search Results

1

Optimal Selection of Patients with Genitourinary Cancers for Anti-PD1/PD-L1 Treatment with a Focus on Urothelial and Renal Cell Carcinoma.

Zeuschner P, Junker K. Zeuschner P, et al. Eur Urol Focus. 2022 Jul;8(4):907-909. doi: 10.1016/j.euf.2022.07.002. Epub 2022 Jul 30. Eur Urol Focus. 2022. PMID: 35918269 Review.

2

Human Papillomavirus-Associated Invasive Condylomas in a Man with Immunosuppressive Comorbidities.

Zeuschner P, Ueberdiek S, Pryalukhin A, Veith C, Saar M, Smola S, Bohle RM, Junker K, Stöckle M, Heinzelbecker J. Zeuschner P, et al. Urol Int. 2019;102(2):238-242. doi: 10.1159/000491098. Epub 2018 Aug 21. Urol Int. 2019. PMID: 30130762

3

Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations.

Grimm J, Zeuschner P, Janssen M, Wagenpfeil S, Hartmann A, Stöhr C, Keck B, Kahlmeyer A, Stöckle M, Junker K. Grimm J, et al. Among authors: zeuschner p. Genes Chromosomes Cancer. 2019 Sep;58(9):612-618. doi: 10.1002/gcc.22749. Epub 2019 Mar 28. Genes Chromosomes Cancer. 2019. PMID: 30851148

4

[Personalised medicine in renal cell tumours].

Junker K, Zeuschner P. Junker K, et al. Among authors: zeuschner p. Aktuelle Urol. 2019 Sep;50(5):513-523. doi: 10.1055/a-0895-9201. Epub 2019 Jun 5. Aktuelle Urol. 2019. PMID: 31167243 Review. German.

5

4-miRNA Score Predicts the Individual Metastatic Risk of Renal Cell Carcinoma Patients.

Heinzelmann J, Arndt M, Pleyers R, Fehlmann T, Hoelters S, Zeuschner P, Vogt A, Pryalukhin A, Schaeffeler E, Bohle RM, Gajda M, Janssen M, Stoeckle M, Junker K. Heinzelmann J, et al. Among authors: zeuschner p. Ann Surg Oncol. 2019 Oct;26(11):3765-3773. doi: 10.1245/s10434-019-07578-3. Epub 2019 Jul 3. Ann Surg Oncol. 2019. PMID: 31270716

6

Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.

Zeuschner P, Linxweiler J, Junker K. Zeuschner P, et al. Expert Rev Mol Diagn. 2020 Feb;20(2):151-167. doi: 10.1080/14737159.2019.1665998. Epub 2019 Sep 18. Expert Rev Mol Diagn. 2020. PMID: 31499007 Review.

7

[New aspects in the treatment of localized renal cell carcinoma].

Zeuschner P, Siemer S. Zeuschner P, et al. Urologe A. 2020 Feb;59(2):142-148. doi: 10.1007/s00120-019-01105-8. Urologe A. 2020. PMID: 31974660 German.

8

Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model.

Linxweiler J, Hajili T, Körbel C, Berchem C, Zeuschner P, Müller A, Stöckle M, Menger MD, Junker K, Saar M. Linxweiler J, et al. Among authors: zeuschner p. Sci Rep. 2020 Jul 28;10(1):12575. doi: 10.1038/s41598-020-69424-x. Sci Rep. 2020. PMID: 32724081 Free PMC article.

9

Characterization of CD147, CA9, and CD70 as Tumor-Specific Markers on Extracellular Vesicles in Clear Cell Renal Cell Carcinoma.

Himbert D, Zeuschner P, Ayoubian H, Heinzelmann J, Stöckle M, Junker K. Himbert D, et al. Among authors: zeuschner p. Diagnostics (Basel). 2020 Dec 2;10(12):1034. doi: 10.3390/diagnostics10121034. Diagnostics (Basel). 2020. PMID: 33276608 Free PMC article.

10

Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management.

Linxweiler J, Sprenk J, Cascetta K, Pryalukhin A, Hölters S, Zeuschner P, Nini A, Al-Kailani Z, Ezziddin S, Bohle RM, Fries P, Ohlmann CH, Heinzelbecker J, Siemer S, Stöckle M, Junker K, Saar M. Linxweiler J, et al. Among authors: zeuschner p. J Urol. 2021 Jul;206(1):88-96. doi: 10.1097/JU.0000000000001697. Epub 2021 Feb 22. J Urol. 2021. PMID: 33617326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page